vs

Side-by-side financial comparison of CODEXIS, INC. (CDXS) and NEWMARKET CORP (NEU). Click either name above to swap in a different company.

NEWMARKET CORP is the larger business by last-quarter revenue ($669.7M vs $38.9M, roughly 17.2× CODEXIS, INC.). CODEXIS, INC. runs the higher net margin — 24.7% vs 17.6%, a 7.0% gap on every dollar of revenue. On growth, CODEXIS, INC. posted the faster year-over-year revenue change (81.3% vs -4.5%). Over the past eight quarters, CODEXIS, INC.'s revenue compounded faster (51.0% CAGR vs -2.9%).

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

NewMarket Corporation, is a publicly traded American company that primarily serves the petroleum additives industry. The company is based in Richmond, Virginia, and has operations in North America, Latin America, Europe, the Middle East and Asia Pacific. The company's predecessor, the Albemarle Paper Manufacturing Company, was founded in 1887.

CDXS vs NEU — Head-to-Head

Bigger by revenue
NEU
NEU
17.2× larger
NEU
$669.7M
$38.9M
CDXS
Growing faster (revenue YoY)
CDXS
CDXS
+85.8% gap
CDXS
81.3%
-4.5%
NEU
Higher net margin
CDXS
CDXS
7.0% more per $
CDXS
24.7%
17.6%
NEU
Faster 2-yr revenue CAGR
CDXS
CDXS
Annualised
CDXS
51.0%
-2.9%
NEU

Income Statement — Q4 2025 vs Q1 2026

Metric
CDXS
CDXS
NEU
NEU
Revenue
$38.9M
$669.7M
Net Profit
$9.6M
$118.1M
Gross Margin
94.8%
33.0%
Operating Margin
27.1%
21.4%
Net Margin
24.7%
17.6%
Revenue YoY
81.3%
-4.5%
Net Profit YoY
192.5%
-6.3%
EPS (diluted)
$0.13
$12.62

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CDXS
CDXS
NEU
NEU
Q1 26
$669.7M
Q4 25
$38.9M
$635.4M
Q3 25
$8.6M
$690.3M
Q2 25
$15.3M
$698.5M
Q1 25
$7.5M
$700.9M
Q4 24
$21.5M
$654.6M
Q3 24
$12.8M
$724.9M
Q2 24
$8.0M
$710.2M
Net Profit
CDXS
CDXS
NEU
NEU
Q1 26
$118.1M
Q4 25
$9.6M
$81.3M
Q3 25
$-19.6M
$100.3M
Q2 25
$-13.3M
$111.2M
Q1 25
$-20.7M
$125.9M
Q4 24
$-10.4M
$110.7M
Q3 24
$-20.6M
$132.3M
Q2 24
$-22.8M
$111.6M
Gross Margin
CDXS
CDXS
NEU
NEU
Q1 26
33.0%
Q4 25
94.8%
30.0%
Q3 25
71.3%
30.4%
Q2 25
86.3%
31.6%
Q1 25
63.8%
33.7%
Q4 24
83.0%
31.7%
Q3 24
66.4%
33.6%
Q2 24
56.6%
30.8%
Operating Margin
CDXS
CDXS
NEU
NEU
Q1 26
21.4%
Q4 25
27.1%
17.3%
Q3 25
-220.3%
18.9%
Q2 25
-83.9%
20.5%
Q1 25
-271.6%
22.8%
Q4 24
-34.2%
20.3%
Q3 24
-129.0%
23.4%
Q2 24
-284.9%
20.7%
Net Margin
CDXS
CDXS
NEU
NEU
Q1 26
17.6%
Q4 25
24.7%
12.8%
Q3 25
-228.1%
14.5%
Q2 25
-86.6%
15.9%
Q1 25
-274.3%
18.0%
Q4 24
-48.4%
16.9%
Q3 24
-160.8%
18.3%
Q2 24
-285.2%
15.7%
EPS (diluted)
CDXS
CDXS
NEU
NEU
Q1 26
$12.62
Q4 25
$0.13
$8.67
Q3 25
$-0.22
$10.67
Q2 25
$-0.16
$11.84
Q1 25
$-0.25
$13.26
Q4 24
$-0.12
$11.57
Q3 24
$-0.29
$13.79
Q2 24
$-0.32
$11.63

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CDXS
CDXS
NEU
NEU
Cash + ST InvestmentsLiquidity on hand
$78.2M
$73.2M
Total DebtLower is stronger
$40.1M
$939.6M
Stockholders' EquityBook value
$50.5M
$1.7B
Total Assets
$147.8M
$3.5B
Debt / EquityLower = less leverage
0.79×
0.54×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CDXS
CDXS
NEU
NEU
Q1 26
$73.2M
Q4 25
$78.2M
$77.6M
Q3 25
$58.7M
$102.5M
Q2 25
$66.3M
$70.3M
Q1 25
$59.8M
$118.3M
Q4 24
$73.5M
$77.5M
Q3 24
$90.3M
$80.3M
Q2 24
$73.2M
$87.6M
Total Debt
CDXS
CDXS
NEU
NEU
Q1 26
$939.6M
Q4 25
$40.1M
$883.4M
Q3 25
$39.7M
$783.1M
Q2 25
$39.4M
$841.8M
Q1 25
$29.2M
$990.6M
Q4 24
$28.9M
$971.3M
Q3 24
$28.6M
$1.1B
Q2 24
$28.4M
$1.2B
Stockholders' Equity
CDXS
CDXS
NEU
NEU
Q1 26
$1.7B
Q4 25
$50.5M
$1.8B
Q3 25
$38.5M
$1.7B
Q2 25
$55.6M
$1.6B
Q1 25
$49.6M
$1.5B
Q4 24
$66.9M
$1.5B
Q3 24
$73.4M
$1.4B
Q2 24
$61.4M
$1.2B
Total Assets
CDXS
CDXS
NEU
NEU
Q1 26
$3.5B
Q4 25
$147.8M
$3.5B
Q3 25
$124.0M
$3.2B
Q2 25
$138.2M
$3.2B
Q1 25
$128.9M
$3.2B
Q4 24
$149.0M
$3.1B
Q3 24
$148.2M
$3.2B
Q2 24
$132.0M
$3.2B
Debt / Equity
CDXS
CDXS
NEU
NEU
Q1 26
0.54×
Q4 25
0.79×
0.50×
Q3 25
1.03×
0.46×
Q2 25
0.71×
0.52×
Q1 25
0.59×
0.65×
Q4 24
0.43×
0.66×
Q3 24
0.39×
0.80×
Q2 24
0.46×
0.95×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CDXS
CDXS
NEU
NEU
Operating Cash FlowLast quarter
$20.1M
Free Cash FlowOCF − Capex
$19.6M
FCF MarginFCF / Revenue
50.3%
Capex IntensityCapex / Revenue
1.3%
3.6%
Cash ConversionOCF / Net Profit
2.09×
TTM Free Cash FlowTrailing 4 quarters
$-23.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CDXS
CDXS
NEU
NEU
Q1 26
Q4 25
$20.1M
$145.2M
Q3 25
$-7.7M
$142.4M
Q2 25
$-18.0M
$161.1M
Q1 25
$-13.8M
$120.3M
Q4 24
$-16.5M
$185.2M
Q3 24
$-13.0M
$116.6M
Q2 24
$-12.2M
$115.0M
Free Cash Flow
CDXS
CDXS
NEU
NEU
Q1 26
Q4 25
$19.6M
$117.2M
Q3 25
$-7.9M
$122.1M
Q2 25
$-20.5M
$144.8M
Q1 25
$-15.1M
$107.3M
Q4 24
$-18.2M
$170.6M
Q3 24
$-14.0M
$102.4M
Q2 24
$-12.6M
$100.0M
FCF Margin
CDXS
CDXS
NEU
NEU
Q1 26
Q4 25
50.3%
18.4%
Q3 25
-91.7%
17.7%
Q2 25
-133.6%
20.7%
Q1 25
-199.6%
15.3%
Q4 24
-85.0%
26.1%
Q3 24
-109.0%
14.1%
Q2 24
-157.5%
14.1%
Capex Intensity
CDXS
CDXS
NEU
NEU
Q1 26
3.6%
Q4 25
1.3%
4.4%
Q3 25
2.1%
2.9%
Q2 25
16.4%
2.3%
Q1 25
16.7%
1.9%
Q4 24
8.3%
2.2%
Q3 24
7.8%
2.0%
Q2 24
5.0%
2.1%
Cash Conversion
CDXS
CDXS
NEU
NEU
Q1 26
Q4 25
2.09×
1.79×
Q3 25
1.42×
Q2 25
1.45×
Q1 25
0.96×
Q4 24
1.67×
Q3 24
0.88×
Q2 24
1.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons